Addex Therapeutics Ltd ADXN:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
10.47quote price arrow down-0.07 (-0.66%)
Volume
8,387
52 week range
6.19 - 37.52

...

Loading . . .

KEY STATS

  • Open10.62
  • Day High10.79
  • Day Low10.39
  • Prev Close10.54
  • 52 Week High37.52
  • 52 Week High Date08/07/20
  • 52 Week Low6.19
  • 52 Week Low Date03/23/20
  • Market Cap47M
  • Shares Out4.46M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Addex Therapeutics Ltd News

There is no recent news for this security.

Latest ADXN News From Our Partners

QUOTE FINDER

Profile

MORE
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration...
Vincent Lawton
Non-Executive Chairman
Tim Dyer
Chief Executive Officer
Address
Chemin des Mines, 9
Plan-les-ouates
1202
Switzerland